4-[(4R,7S,8S,9S)-14-fluoro-17-[[1-[[(3S)-3-fluoropyrrolidin-1-yl]methyl]cyclopropyl]methoxy]-9-methyl-10-oxa-2,12,16,18,20-pentazapentacyclo[9.7.1.14,7.02,8.015,19]icosa-1(18),11,13,15(19),16-pentaen-13-yl]-6-methyl-5-(trifluoromethyl)pyridin-2-amine
C31H35F5N8O2 — CID 170422820
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(4R,7S,8S,9S)-14-fluoro-17-[[1-[[(3S)-3-fluoropyrrolidin-1-yl]methyl]cyclopropyl]methoxy]-9-methyl-10-oxa-2,12,16,18,20-pentazapentacyclo[9.7.1.14,7.02,8.015,19]icosa-1(18),11,13,15(19),16-pentaen-13-yl]-6-methyl-5-(trifluoromethyl)pyridin-2-amine
4-[(4R,7S,8S,9S)-14-fluoro-17-[[1-[[(3S)-3-fluoropyrrolidin-1-yl]methyl]cyclopropyl]methoxy]-9-methyl-10-oxa-2,12,16,18,20-pentazapentacyclo[9.7.1.14,7.02,8.015,19]icosa-1(18),11,13,15(19),16-pentaen-13-yl]-6-methyl-5-(trifluoromethyl)pyridin-2-amine (PubChem CID 170422820) has the molecular formula C31H35F5N8O2 and a molecular weight of 646.67 g/mol. Its IUPAC name is 4-[(4R,7S,8S,9S)-14-fluoro-17-[[1-[[(3S)-3-fluoropyrrolidin-1-yl]methyl]cyclopropyl]methoxy]-9-methyl-10-oxa-2,12,16,18,20-pentazapentacyclo[9.7.1.14,7.02,8.015,19]icosa-1(18),11,13,15(19),16-pentaen-13-yl]-6-methyl-5-(trifluoromethyl)pyridin-2-amine.
Molecular Properties
| Compound Name | 4-[(4R,7S,8S,9S)-14-fluoro-17-[[1-[[(3S)-3-fluoropyrrolidin-1-yl]methyl]cyclopropyl]methoxy]-9-methyl-10-oxa-2,12,16,18,20-pentazapentacyclo[9.7.1.14,7.02,8.015,19]icosa-1(18),11,13,15(19),16-pentaen-13-yl]-6-methyl-5-(trifluoromethyl)pyridin-2-amine |
|---|---|
| PubChem CID | 170422820 |
| Molecular Formula | C31H35F5N8O2 |
| Molecular Weight | 646.67 g/mol |
| Exact Mass | 646.28 |
| IUPAC Name | 4-[(4R,7S,8S,9S)-14-fluoro-17-[[1-[[(3S)-3-fluoropyrrolidin-1-yl]methyl]cyclopropyl]methoxy]-9-methyl-10-oxa-2,12,16,18,20-pentazapentacyclo[9.7.1.14,7.02,8.015,19]icosa-1(18),11,13,15(19),16-pentaen-13-yl]-6-methyl-5-(trifluoromethyl)pyridin-2-amine |
| SMILES | Cc1nc(N)cc(-c2nc3c4c(nc(OCC5(CN6CC[C@H](F)C6)CC5)nc4c2F)N2C[C@H]4CC[C@H](N4)[C@H]2[C@H](C)O3)c1C(F)(F)F |
| InChI | InChI=1S/C31H35F5N8O2/c1-14-22(31(34,35)36)18(9-20(37)38-14)24-23(33)25-21-27(44-11-17-3-4-19(39-17)26(44)15(2)46-28(21)40-24)42-29(41-25)45-13-30(6-7-30)12-43-8-5-16(32)10-43/h9,15-17,19,26,39H,3-8,10-13H2,1-2H3,(H2,37,38)/t15-,16-,17+,19-,26+/m0/s1 |
| InChIKey | VKVBDFIGDQUXGJ-BHPURNNFSA-N |
| XLogP | 4.43 |
| TPSA | 114.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 46 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 646.67 |
| LogP ≤ 5 | 4.43 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170422820 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.